EPISODE · Jan 31, 2025 · 25 MIN
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 10 Control of Impurities (Organic, Inorganic, Residual Solvents)
from Cannabinoid and Psychedelic Pharmacology and Drug Development
This deep-dive podcast episode explores the critical world of drug impurities and their impact on pharmaceutical safety. The discussion covers the ICH guidelines (Q3A through Q3E) that govern impurity control, sophisticated analytical techniques for detection, and real-world applications in both traditional pharmaceuticals and emerging substances like cannabis and psilocybin. The episode breaks down complex concepts like purge factors, nitrosamine impurities, and hyphenated analytical techniques, while emphasizing the importance of quality control in ensuring safe, effective medications.
Embed this episode
NOW PLAYING
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 10 Control of Impurities (Organic, Inorganic, Residual Solvents)
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.